Bioanalytical services
IVDs are transforming precision medicine by enabling better diagnosis, treatment monitoring, and therapy selection. At Biocult, we leverage decades of expertise in immunoassays and biomarker translation to deliver regulatory-ready diagnostic solutions that accelerate therapeutic success and enhance patient care.
Our capabilities
At Biocult, we support biopharma partners in transforming promising biomarkers into reliable, validated assays. Our expertise spans the full development cycle—from feasibility and optimization to verification and transfer to clinical platforms. With decades of experience and state-of-the-art facilities, we ensure every assay meets the highest standards for accuracy, reproducibility, and regulatory compliance. Together, we accelerate the path from discovery to patient impact.
De-novo assay development
From concept to clinical-grade, we develop fit-for-purpose immunoassays across multiple platforms—tailored to each application and stage of development. Our expertise spans the full range of immunoassay platforms, from plate-based assay to novel detection devices, and related formats such as enzymatic assays. We manage the full process—from sourcing critical raw materials to delivering IVD-grade assays ready for market.
Assay optimization
Struggling internally with assay development challenges? Leverage our decades of know-how to improve your assay’s specificity, reproducibility, or robustness—ensuring reliable results that meet regulatory and clinical demands.
Platform migration & scale-up
We seamlessly transfer assays between platforms while maintaining or enhancing performance. Whether transitioning manual assays to automated analyzers or migrating RUO platforms (MSD, Luminex) into validated IVD-ready systems, we ensure smooth scalability and readiness for clinical deployment.
Verification & validation for pharma-related IVDs
From treatment monitoring to companion and complementary diagnostics, we provide full verification and validation—aligned with global regulatory requirements—to move your biomarker confidently into the IVD space.
VERIFICATION AND VALIDATION
Manufacturing & commercialization
With flexible contract manufacturing, we support immunoassay batch production for validation studies or initial launches. For large-scale rollout, our strong global partnerships with leading IVD providers offer the infrastructure, reach, and commercialization strategies to maximize your assay’s market impact.
MANUFACTURING & COMMERCIALIZATION
Fit-for-purpose immunoassay development across clinical stages
Every stage of a clinical program demands assays that are robust, reliable, and fit-for-purpose. At Biocult, we support pharma and biotech partners with immunoassay solutions that evolve seamlessly with the needs of their drug and biomarker development journey.
From early assay set-ups, pilots, and proof-of-concepts to research-use-only (RUO) formats, we deliver exploratory assays that generate meaningful insights at the discovery stage. As programs mature, we transition these assays into validated clinical biomarker assays that withstand regulatory scrutiny and deliver reproducible data for decision-making.
Our expertise also covers the critical bridge from RUO to IVD, ensuring smooth migration into regulatory-grade, commercially deployable diagnostics. Whether it’s moving from exploratory biomarker discovery to clinical validation, or transforming RUO assays into full companion or complementary diagnostics, we provide the technical and regulatory know-how to de-risk the process.
By combining deep immunoassay expertise, flexible technology platforms, and regulatory-ready processes, Future Diagnostics ensures that your assays not only meet the scientific demands of each stage, but also align with the long-term strategy of bringing biomarker-driven IVDs to market.
From biomarker to market
Looking to bring the immunoassays supporting your drug development programs to market? Through innovative partnership models, Biocult provides end-to-end services that transform exploratory biomarker assays into market-ready IVDs. Whether you require support during early development, analytical and clinical validation, regulatory approval, manufacturing, or commercialization, our experienced team guides every step of the process.By combining expertise in assay development, validation, contract and legal manufacturing, and regulatory compliance—including CE-IVD, FDA, and ISO 13485:2016 requirements—we ensure a smooth transition from laboratory research to clinical application. Supported by a trusted global network of partners, we also help define and execute commercialization and distribution strategies that maximize market impact.
This integrated approach brings together the agility and personalized focus of a specialized CRO with the scalability and market reach of established IVD leaders, accelerating development timelines and increasing the likelihood of success.
What sets Biocult apart
Decades of proven success
Hundreds of completed projects with top global pharma and diagnostics companies.
Flexible & Transparent Collaboration
We act as an extension of your R&D team, providing milestone-driven projects, transparent timelines, and collaborative problem-solving.
End-to-end capabilities through partnerships
Our hybrid model combines deep technical expertise with global commercialization reach—delivering a smooth path from biomarker discovery to full IVD market adoption.
Specialized expertise
Focused on protein and metabolic biomarker detection, where our immunoassay expertise creates a clear competitive edge.
Regulatory-ready deliverables
ISO 13485:2016 certified processes ensure every assay is compliant, robust, and ready for CE-marking, FDA submission, and global deployment.
Start a Project
Let’s make something great together. Feel free to contact us for more information via the contact form.